Robert A. Copeland, EVP and CSO at Epizyme, Inc. (EPZM), sold 10,000 shares at $21.29 ($213K) on 2014-05-05, disclosed to the SEC on 2014-05-05.
Scheduled sale ($213k) by EVP and CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.29 | 4,900 | $104K | 49.0% |
| 2 | $21.29 | 5,100 | $109K | 51.0% |
| Total | $21.29 avg | 10,000 | $213K | 100% |
| Filing → |
| EPZM | SELL | 2017-04-05 | $41K | — | Filing → |
| EPZM | SELL | 2016-08-03 | $83K | — | Filing → |
| EPZM | SELL | 2016-07-07 | $80K | — | Filing → |